Stifel Nicolaus Boosts Viking Therapeutics (NASDAQ:VKTX) Price Target to $30.00
Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its price objective lifted by Stifel Nicolaus from $25.00 to $30.00 in a research report sent to investors on Tuesday morning, The Fly reports. A number of other equities analysts have also weighed in on the stock. Oppenheimer boosted their price target on shares of Viking Therapeutics from […]